Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Eton Pharmaceuticals Launches Impavido Capsules to Treat Leishmaniasis

Eton Pharmaceuticals Launches Impavido Capsules to Treat Leishmaniasis

MT newswireMT newswire2026/09/28 11:37
07:37 AM EDT, 09/28/2026 (MT Newswires) -- Eton Pharmaceuticals (ETON) said Monday that it launched Impavido (miltefosine) capsules to treat leishmaniasis, a parasitic disease, in adults and adolescents aged 12 and older weighing at least 30 kilograms. The company said its Eton Cares program will provide patient support services, including $0 co-pay for eligible commercially insured patients, while it works to expand hospital availability through a consignment inventory program. Eton also said it will offer an emergency access pathway for urgent patient needs through Anovo Specialty Pharmacy.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Nvidia announces an additional $150 billions stock buyback plan, pre-market stock price rises and turns positive

Nvidia's board has approved an additional $150 billion in stock repurchase authorization, marking the largest single increase in history, bringing the remaining buyback allowance to $235 billion, with plans to complete it by fiscal year 2028. CEO Jensen Huang stated that the transformation driven by AI and accelerated computing platforms is fueling the company’s growth, and strong profits and cash flow are supporting this large-scale buyback. Following the announcement, Nvidia’s pre-market stock price rose by as much as 1.7%, outperforming the declining futures market.

华尔街见闻•2026/09/28 11:56